ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -510.9 Million | 734.8 Million | 63.89 Million | 529.41 Million | -24.34 Million | -56.18 Million |
| Net Income | 479.72 Million | 436.08 Million | 350.59 Million | 266.13 Million | 189.85 Million | 142.42 Million |
| Depreciation & Amortization | 153.02 Million | 145.32 Million | 130.73 Million | 112.28 Million | 88.79 Million | 76.3 Million |
| Deferred income taxes | -8.6 Million | -2.06 Million | -6.37 Million | 3.64 Million | 7.63 Million | -3.97 Million |
| Stock-based compensation | - | - | - | - | - | 316.66 Thousand |
| Change in working capital | -1.22 Billion | 87.21 Million | -471.4 Million | 60.63 Million | -373.28 Million | -334.8 Million |
| Other non-cash items | 1.61 Billion | 66.19 Million | 53.96 Million | 90.35 Million | 70.28 Million | 59.89 Million |
| Investing Cash Flow | -525.82 Million | -696.4 Million | -264.75 Million | -442.14 Million | -322.14 Million | -189.68 Million |
| Investments in PPE | -189.19 Million | -176.02 Million | -280.81 Million | -436.87 Million | -265.72 Million | -139.53 Million |
| Acquisitions | 283.82 Thousand | 43.26 Million | 5.78 Million | 1.03 Million | -86.37 Thousand | 140.37 Million |
| Investment purchases | -455.77 Million | -570.61 Million | -3.24 Million | -10.74 Million | -120.35 Million | -113.05 Million |
| Sales/Maturities of investments | 118.86 Million | 49.82 Million | 15.72 Million | 2.28 Million | 61.41 Million | 62.05 Million |
| Other Investing Activities | 1.00 | -42.84 Million | -2.19 Million | 2.15 Million | 2.6 Million | -139.53 Million |
| Financing Cash Flow | 1.29 Billion | 39.04 Million | 540.96 Million | 242.66 Million | 342.26 Million | 218.12 Million |
| Debt repayment | -1.79 Billion | -3.13 Billion | -1.27 Billion | -2.5 Billion | -1.97 Billion | -1.28 Billion |
| Dividends payments | -181.41 Million | -69.26 Million | -53.27 Million | -24.07 Million | -40.94 Million | -78.04 Million |
| Common Stock Repurchased | -95.83 Million | - | -2.64 Million | -91.88 Million | -147.48 Million | -4.07 Million |
| Common Stock Issuance | - | - | 2.64 Million | 619.3 Million | 147.48 Million | - |
| Other Financing Activities | -403.4 Million | 3.31 Billion | 1.92 Billion | 2.31 Billion | 2.42 Billion | 1.57 Billion |
| Accounts receivables | 135.23 Million | -274.16 Million | -119.08 Million | 59.4 Million | -59.15 Million | -116.05 Million |
| Accounts payables | -211.8 Million | 176.31 Million | 89.99 Million | -110.49 Million | 97.86 Million | -177.3 Million |
| Inventory | -1.14 Billion | 187.12 Million | -435.92 Million | 108.07 Million | -419.62 Million | -37.46 Million |
| Other working capital | -220.4 Million | -2.06 Million | -6.37 Million | 3.64 Million | 7.63 Million | -297.33 Million |
| Cash at beginning of period | 1.6 Billion | 758.72 Million | 422.97 Million | 96.95 Million | 100.05 Million | 125.69 Million |
| Cash at end of period | 1.1 Billion | 831.23 Million | 758.72 Million | 422.97 Million | 96.95 Million | 100.05 Million |
| Capital Expenditure | -189.19 Million | -176.02 Million | -280.81 Million | -436.87 Million | -265.72 Million | -139.53 Million |
| Effect of forex changes on cash | -6.05 Million | -4.93 Million | -4.36 Million | -3.9 Million | 1.13 Million | 2.1 Million |
| Net cash flow / Change in cash | -504.17 Million | 72.51 Million | 335.74 Million | 326.02 Million | -3.09 Million | -25.63 Million |
| Free Cash Flow | -700.1 Million | 558.77 Million | -216.91 Million | 92.53 Million | -290.06 Million | -195.71 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -37.22 Million | 61.24 Million | 38.59 Million | 479.72 Million | 81.36 Million | 99.7 Million |
| Depreciation & Amortization | - | 43.38 Million | 43.38 Million | 153.02 Million | 43.62 Million | 43.62 Million |
| Deferred income taxes | - | - | - | -8.6 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 944.16 Million | - | -1.22 Billion | -1.01 Billion | -604.91 Million |
| Other non-cash items | 604.88 Million | 815.95 Million | 173.92 Million | 1.61 Billion | -684.47 Million | 183.26 Million |
| Investing Cash Flow | -54.84 Million | -200.23 Million | 457.05 Million | -525.82 Million | -444.43 Million | -135.5 Million |
| Investments in PPE | -66.58 Million | -49.34 Million | -34.05 Million | -189.19 Million | -46.83 Million | -51.67 Million |
| Acquisitions | - | 94.14 Thousand | - | 283.82 Thousand | -48.88 Thousand | 18.18 Thousand |
| Investment purchases | -253.5 Million | -390.74 Million | -157.43 Million | -455.77 Million | 450.2 Million | -410.43 Million |
| Sales/Maturities of investments | 265.24 Million | 239.75 Million | 648.53 Million | 118.86 Million | -847.75 Million | 326.59 Million |
| Other Investing Activities | - | 94.14 Thousand | 506.18 Million | 1.00 | -383.11 Million | 0.45 |
| Financing Cash Flow | -429.35 Million | -608.36 Million | 466.16 Million | 1.29 Billion | 1 Billion | 310.76 Million |
| Debt repayment | -503.96 Million | -332.66 Million | -641.58 Million | -1.79 Billion | -1.33 Billion | -879.2 Million |
| Dividends payments | -64.91 Million | -64.91 Million | -29.37 Million | -181.41 Million | -33.54 Million | -20.77 Million |
| Common Stock Repurchased | 301.22 Million | -301.22 Million | - | -95.83 Million | -95.83 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 97.33 Million | 111.06 Million | -175.42 Million | -403.4 Million | -232.55 Million | 1.21 Billion |
| Accounts receivables | - | 130.09 Million | - | 135.23 Million | 135.23 Million | -285.33 Million |
| Accounts payables | - | - | - | -211.8 Million | - | - |
| Inventory | - | 758.24 Million | - | -1.14 Billion | -1.14 Billion | -319.57 Million |
| Other working capital | - | 55.82 Million | - | - | - | - |
| Cash at beginning of period | 2.24 Billion | 2.13 Billion | 1.1 Billion | 1.6 Billion | 2.29 Billion | 1.6 Billion |
| Cash at end of period | 2.32 Billion | 2.59 Billion | 2.13 Billion | 1.1 Billion | 1.1 Billion | 2.09 Billion |
| Capital Expenditure | -66.58 Million | -49.34 Million | -34.05 Million | -189.19 Million | -46.83 Million | -51.67 Million |
| Effect of forex changes on cash | -1.8 Million | -2.51 Million | -2.4 Million | -6.05 Million | -741.65 Thousand | -5.34 Million |
| Net cash flow / Change in cash | 84.1 Million | 458.23 Million | 1.03 Billion | -504.17 Million | -1.19 Billion | 482.99 Million |
| Free Cash Flow | 501.07 Million | 784.46 Million | 178.46 Million | -700.1 Million | -1.61 Billion | 274.91 Million |
ELIS
6771
PVGDF
ODET
HHI
NEXXY